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Abstract 
The study of [‘251]PDGF-BB binding to normal human embryonic lung fibroblasts, quiescent when cultured at sparsity in the presence of minute 
concentrations of homologous PDS, reveals approximately 2 x lo5 bindmg sites for PDGF per cell; this number significantly increases during 
prolonged quiescence of the culture. As late as 48 h after down-regulation of PDGF receptors, the cells restore only partially their capacity to bind 
PDGF. with aged cells (above CPD 45) responding more rapidly and efficiently than younger ones. TGF-j3 significantly enhances restoration of PDGF 
receptors and, in aged cells in particular, its presence results in total receptor ecovery within 24 h, suggesting a concerted a&on of PDGF and TGF-/I 
regulating the proliferation of human fibroblasts in tissue regeneration. 
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1. Introduction 
Human platelet-derived growth factor (PDGF), a po- 
tent mitogen for cells of mesenchymal origin, is a dimeric 
polypeptide occurring in three isoforms: the heterodimer 
AB and the homodimers AA and BB [l-3]. PDGF exerts 
its action by interacting specifically with two membrane 
receptors, termed CI and B, inducing upon binding their 
homo- or heterodimerization. Thus, PDGF-AA binds 
only to cxoz dimer, PDGF-AB to aa or o$?, whereas 
PDGF-BB to all three receptor dimers (aa, c$?, pj?) [2,4]. 
Extensive studies of PDGF binding to its receptors 
have shown that the number of PDGF receptors, the 
ratio of the two receptor types, a well as the dissociation 
constant (&) vary widely between different cell strains 
and lines [4,&l 11. 
In the present report we examine the binding profile 
of PDGF-BB, i.e. the isoform which binds to all classes 
of PDGF receptors, in a cell assay system especially 
developed for this purpose and based on a human em- 
bryonic lung fibroblast strain. In the presence of minute 
*Corresponding author. Fax: (30) (1) 6511767. 
Abbreviations: PDGF, platelet-derived growth factor; TGF-P, trans- 
forming growth factor-beta; PDS, plasma-derived serum; CPD, cell 
population doubling; FBS, fetal bovme serum. 
concentrations of homologous plasma-derived serum 
(0.05% PDS), these cells can be synchronized arrested in 
Go/G, even at sparsity and are highly responsive to mito- 
gens [13]. The resulting cell system provides a valuable 
tool in studying the action of human growth factors 
under conditions which approximate in vitro those pre- 
vailing in the wound [14]. Under these conditions we 
estimated the number of PDGF receptors present in the 
cells and found it to be significantly increased during 
prolonged quiescence. We also observed that the cells 
cannot fully restore their initial binding capacity for 
PDGF long after down-regulation of its receptors, 
whereas aged cells achieve a better receptor recovery in 
the same time periods. 
We have previously found that transforming growth 
factor-beta (TGF-P), a well known multifunctional agent 
secreted from human platelets simultaneously with 
PDGF [5,12], stimulates DNA synthesis in sparse fibro- 
blasts and also acts in synergism with PDGF, a phenom- 
enon which persists throughout cellular in vitro aging 
[14]. In this report we show that this synergism at the 
proliferative level seems to reflect similar events at the 
binding level. In fact, TGF-/3 significantly enhances the 
recovery of PDGF receptors and this effect is more pro- 
nounced in aged cells. It appears that these two growth 
factors act in concert and that their respective interac- 
tions may decisively regulate cellular proliferation. 
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2. Materials and methods 
Z. I. Growth factors 
Human r~ombinant PDGF c-sis (PDGF-BB) ‘2SI-labeiled with 
Bolton and Hunter reagent and human r~ombin~t PDGF c-sis were 
obtained from Amersham (Buckinghamshire, UK); human recombi- 
nant PDGF-AA and TGF-PI from human platelets from Sigma (St. 
Louis. MO); PDGF from human platelets from R&D Systems (Minne- 
apolis, USA). 
.? 2. Cell culture 
Human embryonic lung fibroblasts (Flow 2002) were cultured in 
MEM supplemented with 10% (v/v) FBS as previously described 1131. 
Cells were su~ultured every 7 days at 1:2 split ratio and grown at 37°C 
in a humid atmosphere of 5% CO*. To determine cell numbers, cells 
were harvested with a trypsin-citrate (0250.3%) solution, suspended 
m MEM containing 10% (v/v) FBS and counted in an Improved Double 
Neubauer haemocytometer. Cell viability was determined after incu- 
bating the harvested cells with the vital stain Neutral red and the 
non-vital stain Trypan blue, respectively. 
17.3. Synchronization of the culture and DNA synthesis assay 
The cells were maintained quiescent arrested in G JG, by PDS depri- 
vation as described [13]. Briefly, cells were plated in 35 mm dishes at 
3 x lo3 cellsfcm’ in MEM supplemented with 0.05% PDS, prepared 
from fresh human blood [13). Four days later, with a medium change 
on day 2, the growth factor samples were added at the indicated concen- 
trations along with 0.1 &ii/ml [methyl-‘Hlthymidine (25 Ci/mmol, 
Amersham). 48 h later thymidine incorporation into newly synthesized 
DNA was measured. 
.?.4. Binding studies 
Binding assays were conducted as previously described [14]. Briefly, 
cells were plated at 4-7 x IO3 cells/cm2 in 1Zwell plates in MEM con- 
taining 1% PDS. After 24 h the medium was changed to MEM contam- 
mg 0.05% PDS and renewed every 48 h until the indicated day of the 
experiment. This subconfluent culture maintains a constant number of 
viable cells (3-6 x IO3 cells/cm*, depending on the cell number initially 
plated) for more than two weeks. Binding of the indicated concentra- 
tions of [“‘IIPDGF-BB incubated with the cells at 4°C for 3 h was 
estimated as described [14]. Non-specific binding values were deter- 
mined for a narrow range of PDGF concentrations around Kd (typi- 
cally, 0.5-l 5 ng/ml [‘251]PDGF-BB) in the presence of 50 @ml PDGF- 
BB. A greater excess of unlabelled PDGF-BB did not affect 
[‘2sI]PDGF-BB binding. Non-specific binding for the other [“‘I]PDGF- 
BB concentrations used was calculated from the above values according 
to Bowen-Pope and Ross @I. Scatchard analysis was performed using 
the Ligand programm by Munson and Rodbard [15] as modified by 
McPherson [16]. PDGF receptor numbers per cell were calculated from 
B,,, values divided by the numbers of cells remaining viable after the 
binding assay procedure. 
2.5 Down-regulation assay 
Cells prepared as above for the binding assay, were incubated for 1 h 
at 37°C.with the indicated PDGF-BB co~~nt~ations in binding buffer 
(MEM buffered with 25 mM HEPES at nH 7.4 containine 2.5 ma/ml 
BSA). Following extensive washing (PBS containing 5.01 msml 
CaCl, 2H,O, 0.01 mglml MGSO, .7H,O and 0. I mg/ml BSA) we incu- 
bated the cells with or without TGF-p in binding buffer for the indi- 
cated time periods, allowing for restoration of their PDGF binding 
capacity. The recovery of PDGF receptors was estimated by the 
[‘“‘IIPDGF-BB binding assay as above. 
Note: During the long incubation period following TGIF-@ addition (up 
to 72 h) minor cell number differences are observed, which do not 
interfere with the estimation of PDGF binding reported here. 
3. Results and discussion 
3.1. Characteristics of PDGF binding to human 
embryonic jibroblasts 
As shown in Fig. lA, specific binding of [‘*‘I]PDGF- 
BB to young (CPD 21) human embryonic lung fibro- 
blasts reached saturation at a ligand concentration of 
approx. 5 r&ml. A linear Scatchard plot was obtained, 
indicating the presence of a single class of receptors with 
an apparent K,, of 50 pM (Fig. 1B). Nevertheless, as 
shown in Fig. 2, the AA dimer had a very low, yet 
distinct stimulatory effect on DNA synthesis, suggesting 
the presence of a limited population of type ot receptors 
besides that of the j? type, a finding widely encountered 
in normal human fibroblasts [17,1X] and also confirmed 
by us in cross-com~tition binding studies (not shown 
here). 
Under the above conditions, i.e. synchronization at 
cell sparsity, the total number of PDGF receptors (both 
01 and p) in early passage cultures (CPD 21) was esti- 
mated to be approx. 2 x 10’ per cell (Fig. 1B). 
3.2. Prolonged quiescence increases PDGF binding in a 
manner similar to in vitro aging 
Aged cells (CPD 49) bind significantly higher amounts 
of PDGF-BB in comparison to younger ones (CPD 21) 
due to a significant increase in receptor number (approx. 
40%) as demonstrated by Scatchard analysis; no signifi- 
cant change in Kd was thereby observed (Fig. 1B). 
Similarly, we noticed that higher amounts of PDGF- 
BB are bound following longer quiescence of the cells. 
Analysis of the binding data for cells of CPD 37 main- 
tained quiescent for an additional week shows that in- 
creased binding is again a consequence of increased re- 
ceptor levels (approx. 40%), with no significant change 
in Kd (Fig. lC,D). 
In similar experiments with human foreskin fibro- 
blasts, Gerhard et al. recently reported higher PDGF 
receptor levels during in vitro aging which they ascribed 
to the increased surface area of aged cells [21]. An analo- 
gous explanation could also apply to the case of pro- 
longed quiescence reported here, although no informa- 
tion is available to our knowledge on cell-size alterations 
during this state. 
3.3. Time course of PDGF receptor ecovery after 
down-regulation 
Following binding, PDGF receptors dimerize, cluster 
in coated pits and become internalized, resulting in their 
down-regulation, a process which has been already well 
characterized [22-241. In our system, after one hour of 
incubation at 37°C with excess PDGF-BB, we found a 
80-85% reduction of [‘251]PDGF-BB binding capacity 
(Fig. 3). 
As indicated by the kinetics of receptor recovery, 
young cells gradually increase their PDGF receptor lev- 
els, beginning 18 hours after down-regulation, but finally 
regain less than 50% of their initial binding capacity (48 
h, Fig. 3A). In contrast, as shown in Fig. 3B, restoration 
of cell-surface PDGF receptors in aged cells begins ap- 
proximately at 12 h and is significantly higher. 
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Fig. 1. (A) Effect of in vitro agmg on PDGF binding. Cells of CPD 21 and 49 were prepared for binding assay as described in section 2. On day 
5 after plating the cells were incubated with the indicated concentrations of [‘ZSI]PDGF-BB. Bound PDGF-BB was measured as described. (B) 
Scatchard plots of binding data in A. The number of viable cells of CPD 21 and CPD 49 after the binding assay procedure was 2.4 x 10Vwell and 
1 x lOVwel1, respectively. (C) Effect of prolonged quiescence on PDGF binding. Cells of CPD 37 were incubated with the indicated concentrations 
of [‘251]PDGF-BB on day 7 (7d) and 15 (15d). respectively, after initial plating. PDGF binding was estimated as above. (D) Scatchard plots of binding 
data in C. Number of viable cells: 4.3 x 10Vwell and 3.6 x 10Vwell for 7 day (7d)- and 15 day (15d)-old culture, respectively. 
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Fig. 2. Stimulation of DNA synthesis by PDGF isoforms. Cells of CPD 
32 were synchronized as described in section 2. On day 4 after plating, 
0.05% PDS in MEM was added containing: PDGF-AA (10 @ml); 
PDGF-AB (10 @ml); PDGF-BB (10 @ml). After 48 h [‘Hlthymidine 
incorporation was measured. 0.05% PDS in MEM was used as control 
(0. 
Normally, fibroblasts are exposed in vivo to extremely 
low concentrations of PDGF present in the human inter- 
stitial fluid [25]. In tissue lesion, platelets aggregate and 
subsequently release their contents resulting in high local 
concentrations of PDGF which probably could induce 
down-regulation of its receptors. However, as our in 
vitro results suggest, the cells need extremely long time 
periods (over 48 h, Fig. 3) to regain their capacity for full 
response to PDGF. This slow process may serve as a 
negative regulatory mechanism preventing an uncon- 
trolled proliferation induced by the excessive supply of 
PDGF. Conversely, the ability of older cells to restore 
their PDGF receptors more rapidly (Fig. 3B) may par- 
tially counterbalance their markedly diminished prolifer- 
ative response to PDGF [13,26]. 
Similar levels of restoration were reported recently in 
human foreskin fibroblasts of intermediate passages by 
Eriksson et al. [27]. In these cells the recovery begins as 
early as 8 h after addition of 20 ng/ml PDGF-BB and 
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Fig. 3. Effect of TGF-/? on the restoration of PDGF receptors. (A) Cells of CPD 34 were plated at 3.1 x 10“ cells/well. After 5 days, they were incubated 
with 20 ng/ml PDGF-BB for 1 h at 37”C, followed by an incubation for the indicated time periods (I) with or (II) without 2 ng/ml TGF-/X 
Subsequently, the binding of 1 ng/ml [‘251]PDGF-BB was measured as in Fig. 1.100% refers to 610 cpm of bound [‘?]PDGF-BB. Non-specific binding 
was not subtracted. (B) Cells of CPD 48 were plated at 3.1 x 104/well and further treated as in A. 100% refers to 902 cpm of bound [‘*‘I]PDGF-BB. 
reaches a plateau after 12 h, an effect which the authors 
ascribe to enhanced PDGF-receptor biosynthesis timu- 
lated by the BB dimer [27]. This more rapid recovery 
could be explained by the fact that those measurements 
were performed in the continuous presence of PDGF, 
whereas in the experiments we report here the latter was 
completely removed from the culture milieu right after 
down-regulation, in order to obtain a rate of recovery 
unaffected by external growth stimuli. 
3.4. TGF-/I stimulates the restoration of PDGF- 
receptors 
When incubated in the presence of TGF-jI, young 
human embryonic fibroblasts with down-regulated 
PDGF receptors, showed significantly higher rates of 
recovery than untreated cells, reaching approximately 
80% of their initial binding capacity for PDGF within 
48 h (Fig. 3A). Intriguingly, this stimulatory effect of 
TGF- /3 was more pronounced in aged cells: 24 h after 
down- regulation, TGF-B-treated cells of CPD 48 fully 
restore their initial binding capacity for PDGF-BB (Fig. 
3B). Hence, it appears that PDGF binding as well as the 
efficiency of the PDGF-receptor restoration mechanism 
are increased during cellular aging. These findings fur- 
ther support the suggestion that diminished proliferative 
response observed of aged cells to PDGF [13,26] is not 
due to scarcity of receptors but rather to events occurring 
downstream in the signal transduction cascade to the 
nucleus [21,28]. 
TGF-/? has already been reported to modulate posi- 
tively or negatively the expression of PDGF receptors in 
3T3 mouse fibroblasts [19], as well as in human skin 
[11,20] and foreskin [l 1,29,30] fibroblasts. Our results 
suggest hat after depletion of cell-surface PDGF bind- 
ing sites, TGF-B actually restores the ability of human 
fibroblasts to bind and respond to PDGF, thus potenti- 
ating the proliferative action of the latter. This is further 
supported by our recent finding that the two growth 
factors act synergistically in stimulating DNA synthesis 
of cells cultured at sparsity under conditions roughly 
simulating in vitro those prevailing in the wound [14]. 
Since PDGF and TGF-B are contained in, and simulta- 
neously released by platelets upon tissue lesion, it seems 
likely that the two factors may act in tandem rather than 
in a segregated manner, thus controlling by their con- 
certed activities the proliferation of human fibroblasts. 
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